Barriers to accessing essential medicines for kidney disease in low- and lower middle–income countries|Anna Francis, Vivekanand Jha, Robert Kalyesubula et al.|Kidney International|2022Cited by 66
Renal Genetics Clinic: 3-Year Experience in the Cleveland ClinicXin Yee Tan, Xiangling Wang, Chloe Borden et al.|Kidney Medicine|2022Cited by 15
Capacity for the management of kidney failure in the International Society of Nephrology North America and the Caribbean region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)Racquel Lowe-Jones, Susan L. Furth, Isabelle Éthier et al.|Kidney International Supplements|2024Cited by 7
Nurturing Global Leadership, Advocacy, Research, and Collegiality: The Unique Experience of The International Society of Nephrology Emerging Leaders ProgramSabine Karam, Rahul Chanchlani, Muhammad Iqbal Abdul Hafidz et al.|Kidney International Reports|2023Cited by 1
POS-327 BARRIERS TO ACCESSING ESSENTIAL MEDICINES FOR KIDNEY DISEASE: AN INTERNATIONAL SURVEYAnna Francis, Vivekanand Jha, T. Chen et al.|Kidney International Reports|2022Cited by 0